A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Prif Awdur: | Sorno, Rubina Haque |
---|---|
Awduron Eraill: | Khair, Nishat Zareen |
Fformat: | Traethawd Ymchwil |
Iaith: | English |
Cyhoeddwyd: |
Brac University
2024
|
Pynciau: | |
Mynediad Ar-lein: | http://hdl.handle.net/10361/23842 |
Eitemau Tebyg
-
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
gan: Flora, Sanzida Alam
Cyhoeddwyd: (2024) -
A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
gan: Khan, Muidul Hasan
Cyhoeddwyd: (2024) -
In silico modelling and structural dynamics of PSY1R kinase domain and its interaction with SERK1 kinase
gan: Ruhee, Noshin Nawer
Cyhoeddwyd: (2022) -
Arresting tumor cell proliferation and inhibition of AKT pathway via the use of multikinase inhibitor sorafenib forthe treatment of glioblastoma
gan: Raju, Md. Ismail
Cyhoeddwyd: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
gan: Ratu, Tabassum
Cyhoeddwyd: (2024)